Abstract
Aim
The purpose of this study was to examine the influence of previous infection with cytomegalovirus (CMV) or Epstein Barr virus (EBV) on the incidence, severity and duration of upper respiratory tract infections (URTIs) in endurance athletes during a 4-month winter training period.
Methods
Blood samples were obtained from 236 subjects (166 males and 70 females, aged 18–35 years) at the start of the study period. Plasma samples were analysed for CMV and EBV serostatus. Weekly training and daily illness logs were kept for the next 16 weeks.
Results
With regard to CMV/EBV serostatus, the results indicated that athletes with previous CMV infection (n = 58, 25 % of cohort) had significantly fewer URTI symptom days (median 2 vs. 4 days, p = 0.033) during the study period than those with no previous infection (n = 178, 75 %), whereas positive EBV serostatus (n = 197, 84 %) had no influence on URTI episode incidence, severity or duration. Moreover, we found that athletes with prior infection of both CMV and EBV (n = 50, 21 %) had 50 % fewer URTI episodes (p = 0.04) and symptom days (median 2 vs 8 days, p = 0.01) than athletes who were seronegative for both CMV and EBV (n = 31, 13 %).
Conclusions
Previous coinfection with CMV and EBV might promote protective immune surveillance to lower the risk of URTI. Further research is required to clarify why previous CMV and EBV infection reduces the incidence of URTI.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bate SL, Dollard SC, Cannon MJ (2010) Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis 50(11):1439–1447
Chang WL, Barry PA (2010) Attenuation of innate immunity by cytomegalovirus IL-10 establishes a long-term deficit of adaptive anti-viral immunity. PNAS 107:22647–22652
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35(8):1381–1395
Fahlman MM, Engels HJ (2005) Mucosal IgA and URTI in American college football players: a year longitudinal study. Med Sci Sports Exerc 37(3):374–380
Gleeson M, Walsh NP (2012) The BASES expert statement on exercise, immunity, and infection. J Sports Sci 30(3):321–324
Gleeson M, Pyne DB, Austin JP, Lynn Francis J, Clancy RL, McDonald WA (2002) Epstein–Barr virus reactivation and upper-respiratory illness in elite swimmers. Med Sci Sports Exerc 34(3):411–417
Gleeson M, Bishop N, Oliveira M, McCauley T, Tauler P, Muhamad AS (2012) Respiratory infection risk in athletes: association with antigen-stimulated IL 10 production and salivary IgA secretion. Scand J Med Sci Sports 22:410–417
Gleeson M, Bishop N, Oliveira M, McCauley T, Tauler P (2013) Influence of training load on upper respiratory tract infection incidence and antigen-stimulated cytokine production in whole blood culture. Scand J Med Sci Sports 23:451–457
He CS, Handzlik M, Fraser WD, Muhamad A, Preston H, Richardson A, Gleeson M (2013) Influence of vitamin D status on respiratory infection incidence and immune function during 4 months of winter training in endurance sport athletes. Exerc Immunol Rev 19:86–101
Jackson GG, Dowling HF, Spiesman IG, Boand AV (1958) Transmission of the common cold to volunteers under controlled conditions: the common cold as a clinical entity. Arch Intern Med 101:267–278
Liu Y, de Waal Malefyt R, Briere F, Parham C, Bridon JM, Banchereau J, Moore KW, Xu J (1997) The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J Immunol 158(2):604–613
Niederman JC, Evans AS, Subrahmanyan L, McCollum RW (1970) Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med 282:361–365
Nieman DC (1994) Exercise, infection, and immunity. Int J Sports Med 15(Suppl 3):S131–S141
Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK (2005) Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. Can Med Assoc J 173(9):1043–1048
Peters EM, Goetzsche JM, Grobbelaar B, Noakes TD (1993) Vitamin C supplementation reduces the incidence of postrace symptoms of upper-respiratory-tract infection in ultramarathon runners. Am J Clin Nutr 57(2):170–174
Pottgiesser T, Wolfarth B, Schumacher YO, Bauer G (2006) Epstein–Barr virus serostatus: no difference despite aberrant patterns in athletes and control group. Med Sci Sports Exerc 38(10):1782–1791
Turner JE, Aldred S, Witard OC, Drayson MT, Moss PM, Bosch JA (2010) Latent cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise. Brain Behav Immun 24(8):1362–1370
Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78(11):5535–5545
Acknowledgments
This study was supported by a grant from the Gatorade Sports Science Institute.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Fabio Fischetti.
Rights and permissions
About this article
Cite this article
He, CS., Handzlik, M., Muhamad, A. et al. Influence of CMV/EBV serostatus on respiratory infection incidence during 4 months of winter training in a student cohort of endurance athletes. Eur J Appl Physiol 113, 2613–2619 (2013). https://doi.org/10.1007/s00421-013-2704-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00421-013-2704-x